Ethylhexyl methoxycrylene
Explore a selection of our essential drug information below, or:
Identification
- Generic Name
- Ethylhexyl methoxycrylene
- DrugBank Accession Number
- DB11226
- Background
Ethylhexyl methoxycrylene is a photostabilizer that preserves the effectiveness of UV filters by interacting with both the singlet and triplet states 6. It returns UV filters to their ground states without absorbing sunlight 6. It is used as a solvent for crystalline UV filters and is easily emulsified and suitable for use in various lotions, creams, sprays, sticks, and gel formulations 6. It currently enjoys regional approvals in Canada, the EU, and the US 3.
- Type
- Small Molecule
- Groups
- Approved, Experimental
- Structure
- Weight
- Average: 391.511
Monoisotopic: 391.214743798 - Chemical Formula
- C25H29NO3
- Synonyms
- Not Available
- External IDs
- RX-14180
Pharmacology
- Indication
Ethylhexyl methoxycrylene is employed as a photostabilizing agent in various sunscreen products 3.
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Associated Conditions
Indication Type Indication Combined Product Details Approval Level Age Group Patient Characteristics Dose Form Used in combination to prevent Sunburn ••• ••• - Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
As an active ingredient in topical sunscreen products, ethylhexyl methoxycrylene is applied directly onto human skin where it acts as a critical component for conferring photostability to the product's other constituent ingredients, protecting the product as a whole from deterioration in the sunlight 3. Additionally, considering the high log Pow value (6.05-6.32) and low water solubility, dermal absorption of ethylhexyl methoxycrylene is expected to be low. This is supported by a dermal absorption of less than 5% observed for an acceptable analogue of the notified chemical 4. Consequently, little systemic exposure and pharmacokinetics are expected and users can freely wash off and re-apply ethylhexyl methoxycrylene containing compounds as necessary.
- Mechanism of action
Ethylhexyl methoxycrylene is a photostabilizer with exceptionally low singlet (S1) and triplet (T1) energy states 1. Given these properties, ethylhexyl methoxycrylene is capable of draining the singlet excited state reservoir of UV radiation excited molecules of various sunscreen agents 5. This action used to be considered impossible because molecules stay in the singlet excited state for a very short period of time - often as short as 13 one-thousandths of a billionth of a second 5. Ethylhexyl methoxycrylene, however, is a singlet quencher that dramatically reduces the flow of energy to the triplet escited state reservoir 5. As it quenches the singlet excited state, molecules do not have the chance to get to the triplet excited state reservoir and largely return to the ground state where they can continue functioning 5. In fact, this mechanism of action of ethylhexyl methoxycrylene is considered as being able to return UV filters to their ground states without absorbing sunlight 6.
Ultimately, because ethylhexyl methoxycrylene can work so quickly, it allows manufacturers to formulate products with combinations of sunscreen ingredients that used to be considered too photo-unstable to be effective 5. Moreover, ethylhexyl methoxycrylene is easily emulsified, and is suitable for use in lotions, creams, sprays, sticks, and gel formulations 6.
- Absorption
Ethylhexyl methoxycrylene is reported as having little to no absorption through the skin 4. At this time, however, studies demonstrate that the components of most commonly used sunscreens are likely absorbed into the skin at least to some extent - although penetration to deeper tissues and the cutaneous circulation remains limited 2. Despite the extensive use of sunscreen products around the world, there have been few reports of adverse effects related to their use 2.
- Volume of distribution
Ethylhexyl methoxycrylene is reported as having little to no absorption through the skin 4. The systemic presence of the compound is consequently expected to be minimal.
- Protein binding
Ethylhexyl methoxycrylene is reported as having little to no absorption through the skin 4. The systemic presence of the compound is consequently expected to be minimal.
- Metabolism
Ethylhexyl methoxycrylene is reported as having little to no absorption through the skin 4. The systemic presence of the compound is consequently expected to be minimal.
- Route of elimination
Ethylhexyl methoxycrylene is reported as having little to no absorption through the skin 4. The systemic presence of the compound is consequently expected to be minimal.
- Half-life
Ethylhexyl methoxycrylene is reported as having little to no absorption through the skin 4. The systemic presence of the compound is consequently expected to be minimal.
- Clearance
Ethylhexyl methoxycrylene is reported as having little to no absorption through the skin 4. The systemic presence of the compound is consequently expected to be minimal.
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Ethylhexyl methoxycrylene is reported as having little to no absorption through the skin 4. The systemic presence of the compound is consequently expected to be minimal. Additionally, no ocular irritation, phototoxicity, dermal irritation, or allergic contact sensitization has been reported to any significant degree 3.
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- No interactions found.
Products
- Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.
- International/Other Brands
- Solastay S1
- Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Almost Makeup SPF 15 Ethylhexyl methoxycrylene (2 g/100g) + Titanium dioxide (13 g/100g) Powder Topical Asanuma Corporation 2007-11-09 2017-10-12 US Almost Makeup SPF 18 Ethylhexyl methoxycrylene (2 g/100g) + Titanium dioxide (1.23 g/100g) Powder Topical Asanuma Corporation 2018-03-01 Not applicable US Sunscreen SPF30 Ethylhexyl methoxycrylene (1.25 g/100g) + Avobenzone (0.75 g/100g) + Benzophenone (0.5 g/100g) + Peg-100 stearate (2.5 g/100g) + Titanium dioxide (4 g/100g) Liquid Topical NINGBO JIANGBEI OCEAN STAR TRADING CO.,LTD 2015-02-20 Not applicable US
Categories
- Drug Categories
- Not Available
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as diphenylmethanes. These are compounds containing a diphenylmethane moiety, which consists of a methane wherein two hydrogen atoms are replaced by two phenyl groups.
- Kingdom
- Organic compounds
- Super Class
- Benzenoids
- Class
- Benzene and substituted derivatives
- Sub Class
- Diphenylmethanes
- Direct Parent
- Diphenylmethanes
- Alternative Parents
- Cinnamic acid esters / Phenoxy compounds / Methoxybenzenes / Anisoles / Fatty acid esters / Alkyl aryl ethers / Enoate esters / Nitriles / Monocarboxylic acids and derivatives / Organopnictogen compounds show 3 more
- Substituents
- Alkyl aryl ether / Alpha,beta-unsaturated carboxylic ester / Anisole / Aromatic homomonocyclic compound / Carbonitrile / Carbonyl group / Carboxylic acid derivative / Carboxylic acid ester / Cinnamic acid ester / Cinnamic acid or derivatives show 17 more
- Molecular Framework
- Aromatic homomonocyclic compounds
- External Descriptors
- Not Available
- Affected organisms
- Humans and other mammals
Chemical Identifiers
- UNII
- S3KFG6Q5X8
- CAS number
- 947753-66-4
- InChI Key
- WAJCJDLRJVDSSD-UHFFFAOYSA-N
- InChI
- InChI=1S/C25H29NO3/c1-4-6-10-19(5-2)18-29-25(27)23(17-26)24(20-11-8-7-9-12-20)21-13-15-22(28-3)16-14-21/h7-9,11-16,19H,4-6,10,18H2,1-3H3
- IUPAC Name
- 2-ethylhexyl 2-cyano-3-(4-methoxyphenyl)-3-phenylprop-2-enoate
- SMILES
- CCCCC(CC)COC(=O)C(C#N)=C(C1=CC=CC=C1)C1=CC=C(OC)C=C1
References
- General References
- Kikuchi A, Hata Y, Kumasaka R, Nanbu Y, Yagi M: Photoexcited singlet and triplet states of a UV absorber ethylhexyl methoxycrylene. Photochem Photobiol. 2013 May-Jun;89(3):523-8. doi: 10.1111/php.12017. Epub 2012 Dec 17. [Article]
- Benson HA: Assessment and clinical implications of absorption of sunscreens across skin. Am J Clin Dermatol. 2000 Jul-Aug;1(4):217-24. [Article]
- Hallstar: SolaStay S1 Product Profile [Link]
- NATIONAL INDUSTRIAL CHEMICALS NOTIFICATION AND ASSESSMENT SCHEME (NICNAS) Public Report On: Ethylhexyl Methoxycrylene [File]
- Sunscreen Photostability 101 [File]
- Hallstar Sun Care Advanced Formulated Solutions Brochure [File]
- External Links
- MSDS
- Download (40.3 KB)
Clinical Trials
- Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package Phase Status Purpose Conditions Count Start Date Why Stopped 100+ additional columns Unlock 175K+ rows when you subscribe.View sample data
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Powder Topical Liquid Topical - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 0.00109 mg/mL ALOGPS logP 6.19 ALOGPS logP 6.63 Chemaxon logS -5.6 ALOGPS pKa (Strongest Basic) -4.8 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 3 Chemaxon Hydrogen Donor Count 0 Chemaxon Polar Surface Area 59.32 Å2 Chemaxon Rotatable Bond Count 11 Chemaxon Refractivity 125.05 m3·mol-1 Chemaxon Polarizability 44.49 Å3 Chemaxon Number of Rings 2 Chemaxon Bioavailability 0 Chemaxon Rule of Five No Chemaxon Ghose Filter No Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
Spectrum Spectrum Type Splash Key Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS splash10-01ox-4149000000-9039a191f411aabef404 Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS splash10-0032-0592000000-85e52b1400d9c246a144 Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS splash10-0bu9-9283000000-021db8de2486c57abd56 Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS splash10-001i-0392000000-6bcade2e73b504ea052f Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS splash10-0ab9-9110000000-50f7e202f731391f10c1 Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS splash10-0059-0981000000-00efbc672fd3cd6dc027 Predicted 1H NMR Spectrum 1D NMR Not Applicable Predicted 13C NMR Spectrum 1D NMR Not Applicable - Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 197.52385 predictedDeepCCS 1.0 (2019) [M+H]+ 200.20418 predictedDeepCCS 1.0 (2019) [M+Na]+ 207.91368 predictedDeepCCS 1.0 (2019)
Drug created at December 03, 2015 16:51 / Updated at October 06, 2020 17:43